Stock presents a bullish technical scenario. REASONS
-breaking the bearish downtrend maintained since March 2018.
-Bullish divergence
-Inverted Head & Shoulders on smaller TF
We could see the price heading to close the GAP in the 58's region.
#BLUE is a candidate I've been watching for weeks.
Bluebird bio is bio tech company that develops therapeutics for genetic diseases and cancer treatment.
I posted this one originally on the 19th. My personal target will be 113.47 but we could ultimately see $137-163 beyond that in time. First target id expect to see is 72.37 if it ends up playing out.
The...
BLUEBIRD BIO:
-Declining sell volume
-Wavetrend indicator suggesting upside
-Struggling with the 21EMA on the weekly Timeframe
ENTRY:
Aggressive
-Laddering in your orders within the current area
Conservative:
-Wait for a weekly close above the 21EMA
good dip entry here, but we could see a little bit more downside until we find the bottom, in my opinion the bottom will be around 30-35 then we can see a test of the downtrend line after that, and obviously even higher if it breaks. leap calls if thats an option. be paytient ;) leave a like/follow if you enjoy ideas <3
Longterm trade - With Covid slowly fading and schools getting back to normal, Biden Admiinsteration, and electric buses, Bird right now is one of the major Bus manufacturers that are already manufacturing electric buses and selling them. Both fundemental and technical analysis.
With 3.42B Market Cap Bluebird Bio after four years again on good level to Buy, Profit Target Primary 70-80 and secondary is 100-140.
You can take this stock from short term to long term.
Hi guys,
Sharing one of my today swingtrades in healtcare on BLUE.
Nice setup for breakout.
If you like the idea, do not forget to support with a 👍 like and follow.
Leave a comment that is helpful or encouraging. Let's master the markets together.
Check out the fundamentals on BLUE! Can't possibly go wrong on this great stock! $55 per share is a bargain! Currently sitting on $1.5B cash with 195M debt-- a ratio of 7.9 cash/debt! AMAZING!
